xxiicentury.comHome Page | 22nd Century Group | XXII

Twitter LinkedIn Instagram YouTube Facebook Search for: Contact Us Search for: What We Do Cigarette Harm Reduction R&D Our Process Our Engine Glossary Investors News Research Contact Us About Our Company Leadership Team Board of Directors Blog Twitter LinkedIn Instagram YouTube Facebook Empowering plants for a healthier future 22nd Century Group, Inc. (Nasdaq: XXII) is a leading agricultural biotechnology company focused on improving health and wellness through plant science. Learn More Our Companies Read more22nd Century Group, Inc. (Nasdaq: XXII) is a next-generation plant biotechnology company, focused on improving human health through plant science. Using our breakthrough, patent-protected IP to control nicotine biosynthesis in the tobacco plant, we have developed the first market-ready, reduced nicotine content (RNC) tobacco plants and cigarettes containing 95% less nicotine. We received the first and only FDA MRTP authorization for a combustible cigarette in December 2021. The sole function of our cigarettes is to make it easier to reduce the number of cigarettes smoked. In tobacco, 22nd Century employs a unique and innovative platform of modern plant breeding technologies, including genetic engineering, gene-editing, and molecular breeding, to deliver healthier solutions for pressing issues. We create new, proprietary plants with select alkaloid, terpenoid, and flavonoid profiles, improved yields, and valuable agronomic traits for the life science and consumer products industries. Learn More What We Do Cigarette Harm Reduction Our primary mission in tobacco is to reduce the harm caused by smoking. Our VLN® reduced nicotine content tobacco cigarettes – containing 95% less nicotine than conventional cigarettes – are the only FDA-authorized cigarette designed to help smokers reduce their intake. Read More Our Goal 134M Years of Life Gained 8M Premature Deaths Avoided 37%+ Less Cigarettes Smoked Per Day Year 0 Month 0 Days 0 Latest News 22nd Century Eliminates an Additional $2.3 Million of Debt 22nd Century Group to Participate in the Aegis Capital Virtual Conference on May 9, 2024 22nd Century Group (XXII) to Announce First Quarter 2024 Results on May 15, 2024 22nd Century Eliminates $5.2 Million of Debt in Above-Market Equity Transaction 22nd Century Group Announces Resignation of Sullivan and Mish from the Board of Directors Sign up for our newsletter Cigarette Harm Reduction Contact UsBoard of Directors Leadership Team Privacy Policy Disclaimer Sitemap Our Process Our Engine Investors News Research Environmental Resource Management Public Health Employees © 2023 22nd Century Group, Inc. All Rights...